Stratec to sell diagnostics unit Diatron to Indian investors
- Location
- Birkenfeld · 🇩🇪 Germany
- Sector
- Healthcare
- Organisations
- Indisches Investorenkonsortium ↔ Diatron MI (Tochter von STRATEC SE)
- Transaction
- Sale of subsidiary
- Volume
- Fixed price €10.0m
- Status
- announced
STRATEC has signed a contract to sell its subsidiary Diatron MI, with its haematology and clinical chemistry products, to an Indian investor consortium. The fixed price is €10.0m, plus performance-related components. The unit is expected to generate about €20m in revenue and an adjusted EBIT of roughly minus €10m in 2026; STRATEC books impairments of €44.1m in the third quarter and lowers its outlook. Closing is expected in the fourth quarter of 2026 (STRATEC SE, ad hoc release, 30 October 2026).
Source: finanznachrichten.de ↗ · Archived copy ↗
Evidence: one source · archived copy saved · How well sourced is Eurotrack?
More from: 🇩🇪 Germany